San Francisco, 18 December 2024: The Report Tangential Flow Filtration Market Size, Share & Trends Analysis Report By Product, By Technology (Ultrafiltration, Microfiltration), By Application (Protein Purification), By End-use, By Region, And Segment Forecasts, 2030 - 2030

The global tangential flow filtration market size is expected to reach USD 4.13 billion by 2030, registering to grow at a CAGR of 12.4% from 2030 to 2030 according to a new report by Grand View Research, Inc. The major factors contributing to the market growth are the advantages offered by tangential flow filtration (TFF) over normal flow filtration, the increasing demand for vaccines and therapeutics derived from bioprocessing operations, and the rising investments for exhaustive R&D activities to develop new technologies in TFF.

The use of TFF technology increased during the COVID-19 pandemic as the separation process was widely employed during the vaccine manufacturing process. TFF products observed an increased adoption during COVID-19 research for the development and manufacturing of vaccines as treatment plans. The pandemic also witnessed an increase in the usage of single-use bioprocessing systems, which further fueled the market expansion. In addition, several initiatives by the governments and key manufacturers were introduced to boost the vaccine development for curbing the spread of SARS-CoV-2 infection. For instance, in April 2021, Meissner Filtration Products, Inc. announced that it has secured a contract of USD 13.4 million from the U.S. government, BARDA (Biomedical Advanced Research and Development Authority) to expand its capacity and produce single-use systems to support the manufacturing of vaccines for COVID-19. Thereby, the increased production of vaccines has positively impacted the TFF product demand and fueled its growth.

TFF or sometimes referred to as cross-flow filtration is a technique used for the separation and purification of molecules, wherein the feed solution flows in a parallel direction to the membrane filter. During this process, some of the flow streams pass through the filter while the rest is concentrated by recirculation in the system. The TFF technology is utilized across both upstream and downstream processes due to its numerous advantages such as low running costs, enhanced control and efficiency, reduced cross-contamination, easy scale-up or down, and increased shelf life. These advantages have allowed TFF application in a range of fields such as biochemistry, molecular biology, and immunology. Additionally, the increasing demand for biopharmaceuticals due to lesser side effects, personalized treatments, and novel therapies has resulted in the expansion of manufacturing capabilities. CMOs and CROs also witnessed a rise in the manufacturing of vaccines and therapeutics due to the upswing in the demand for commercial biopharmaceuticals. For instance, in June 2022, Merck KGaA announced expanding its existing CDMO facility in Wisconsin, USA. This new expansion project of USD 58 million (EUR 59 million) is targeted to increase the production of highly potent active pharmaceutical ingredients for meeting the growing demand for therapies for critical cancer. The rise in the manufacturing of and demand for biopharmaceuticals attributes to the adoption of TFF products across harvesting, separation, and purification processes, therefore propelling the growth of the marketplace.

Request sample report of Tangential Flow Filtration Market@ https://www.grandviewresearch.com/industry-analysis/tangential-flow-filtration-market-report/request/rs1

This growth is attributed to the advancements in biotechnology and biopharmaceuticals as the demand for effective therapies and vaccines rises. In addition, the increased prevalence of chronic diseases and the growing focus on precision medicine fuel market growth. Moreover, the rapid adoption of single-use technologies enhances operational efficiency, while substantial investments in research and development by pharmaceutical companies support innovation in filtration technologies.

Tangential Flow Filtration Market Report Highlights

• Single-use tangential flow filtration (TFF) systems led the market and accounted for the largest revenue share of 42.0% in 2024 attributed to the increasing adoption of single-use technologies across pharmaceutical companies, contract organizations, and research institutions.
• Ultrafiltration technology dominated the market and accounted for the largest revenue share, 55.8%, in 2024, owing to the rising demand for ultrapure water in the food and beverage, pharmaceuticals, and wastewater treatment sectors. In addition, stringent regulatory requirements regarding water quality and environmental sustainability compel industries to implement advanced filtration technologies.
• Raw material filtration led the market and accounted for the largest revenue share in 2024, owing to the increasing demand for high-quality raw materials across various industries, particularly in pharmaceuticals and food and beverage.
• Pharmaceutical and biotechnology companies dominated the market and accounted for the largest revenue share of 44.0% in 2024 attributed primarily to the increasing demand for biopharmaceuticals.

Tangential flow filtration (TFF), or crossflow filtration, is a critical technology widely used in biopharmaceuticals. It is particularly effective for protein purification, virus filtration, and various downstream processing tasks. The growing difficulty of bioprocessing workflows and the need for effective filtration methods have led to an increased adoption of TFF systems. This technique excels at handling large feed volumes while safeguarding the accurate separation of target molecules from mixtures, making it essential for biopharmaceutical filtration.

Tangential Flow Filtration Market Report Scope

Significant investments by pharmaceutical companies are accelerating the development and implementation of TFF technologies. In addition, firms are increasingly directing resources toward bioprocessing and biomanufacturing to improve production efficiencies and meet the rising demand for biopharmaceuticals. This funding surge fosters the creation of more advanced TFF systems, which are vital for scaling up biologics production, subsequently impacting overall market growth.

Moreover, single-use TFF systems have gained traction as they remove the extensive cleaning and validation procedures required by traditional reusable systems. This not only saves time but also reduces operational costs related to bioprocessing. As a result, these systems are rapidly being integrated into both small-scale and large-scale biopharmaceutical production processes, further propelling market expansion.